Minoryx Therapeutics
PrivateLast Round
Grant
May 28, 2024
Total Funding Raised
$137.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Minoryx Therapeutics is a clinical-stage biotechnology company that discovers and develops novel treatments for severe, orphan diseases of the central nervous system (CNS) with high unmet medical need.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minoryx Therapeutics Comparables
Compare Minoryx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Poxel SA | 73% | |
| Viking Therapeutics, Inc. | 72% | |
| Spur Therapeutics | 71% | |
Minoryx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 28, 2024 | ||||
| Series C | May 31, 2022 | ||||
| Debt | Oct 30, 2020 | ||||
| Series B | Sep 26, 2018 | ||||
| Series A | Oct 14, 2015 | ||||
Seed | Oct 1, 2015 |
Minoryx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series B, Series C |
| Roche Venture Fund | Series B, Series A, Series C |
| CDTI Innvierte | Series C |
| Fund+ | Series C, Series B |
| Ysios Capital | Series B, Series C, Series A |
| Wallonie Entreprendre | Series B, Series C |
| Horizon 2020 Programme | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 44% MoM, reaching 6.9K.
- Jan 25, 2026
Monthly visitors grew 107% MoM, reaching 9.6K.
Minoryx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Minoryx Therapeutics's valuation, stock price, and market status.